A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Enrolling by invitation · NCT07262268 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia | Channelopathies, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, erythromelalgia, generalized epilepsy with febrile seizures plus, type 7, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder, peripheral vascular disease, primary erythermalgia, vascular disorder | Enrolling by invitation | Phase 1 | 2026-04-08 | NCT07262268 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biohaven Therapeutics Ltd. | 13 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site-001 | New Haven | United States | 1 |